May 31, 2021

Primary Sclerosing Cholangitis

Study title A Randomized, Double-blind, Dose-ranging, Placebo-controlled, Phase 2a Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Primary Sclerosing Cholangitis (PSC) and […]
May 31, 2021

Primary Sclerosing Cholangitis

Study title Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis (SHIP) Disease or condition Primary sclerosing cholangitis Study type Interventional  (Clinical Trial) Intervention/treatment Sulfasalazine or placebo Phase 2 Study […]
May 31, 2021

Primary Sclerosing Cholangitis

Note: this study is at multiple sites in North Carolina Study title Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis (PRIMIS) […]
JOIN NOW